ResoTher Pharma initiates dosing in its Phase 2a clinical trial in myocardial infarction patients
ResoTher Pharma is pleased to announce that the first patient [...]
We create novel medicines that benefit patients in need
CONTACT
Dronninggaards Alle 136
2840 Holte
Denmark
GET IN TOUCH
Anders Kronborg
akr@resotherpharma.com
We create novel medicines that benefit patients in need
CONTACT
Næsseslottet
Dronninggaards Alle 136
2840 Holte
Denmark
GET IN TOUCH
Anders Kronborg
akr@resotherpharma.com
Copyright © 2022 ResoTher Pharma